BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Large-scale human-yeast genetic interaction for construction of disease network: systematic discovery of multiple drug targets
Kyoungho Suk1,*
1Department of Pharmacology, Brain Science and Engineering Institute, and Department of Biomedical Sciences, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University School of Medicine, Daegu, Korea
A novel approach has been used to identify functional interactions relevant to human disease. Using high-throughput human-yeast genetic interaction screens, a first draft of disease interactome was obtained. This was achieved by firstly searching for candidate human disease genes that confer toxicity in yeast, and secondly identifying modulators of this toxicity. The study found potentially disease-relevant interactions by analyzing the network of functional interactions and focusing on genes implicated in amyotrophic lateral sclerosis (ALS), for instance. In the subsequent proof-of-concept study focused on ALS, similar functional relationships between a specific kinase and ALS-associated genes were observed in mammalian cells and zebrafish, thereby supporting the findings in the human-yeast genetic interaction screens. Finally, results of combined analyses highlighted MAP2K5 kinase as a potential therapeutic target in ALS.
Abstract, Accepted Manuscript(in press) [Submitted on July 6, 2017, Accepted on July 6, 2017]
  Copyright © KSBMB. All rights reserved. / Powered by, Ltd